Entries by Seth Christensen

ALS Crowd Radio S2:E6 Dr. Avindra Nath, MD: An Activated Virus Causing ALS?

Dr. Avindra Nath, MD National Institutes of Health, Clinical Director of National Institute of Neurological Disorders and Stroke (NINDS) Interview Date: May 17, 2016 Dr. Nath is an expert in viruses and retroviruses.  He speaks about studying human endogenous retrovirus-K (HERV-K) in the context of ALS, and why it could be important.  HERV-K is normally dormant, but […]

ALS Crowd Radio S2:E5 Barbara Newhouse & Dr. Lucie Bruijn: ALS Advocacy

Barbara Newhouse, President and CEO Lucie Bruijn, Ph.D. ALS Association Interview Date: May 9, 2016 S2:E5 ALSA President and CEO Barbara Newhouse and Chief Scientist Dr. Lucie Bruijn spoke live from Washington DC at the National ALS Advocacy Day and Public Policy Conference.  They shared the advocacy work on Capitol Hill that the National ALS Association […]

ALS Crowd Radio S2:E4 Dr. Richard Bedlack,MD, PhD, MS Duke University: ALS Reversals

Dr. Richard Bedlack, MD, PhD, MS Duke University Interview Date: May 4, 2016 S2:E4 Dr. Richard Bedlack defines an ALS Reversal, in which a patient with a confirmed diagnosis of ALS regains motor function.  He describes his search for these cases, which has revealed 23 to date.  He started the ALS Reversals Program which includes […]

ALS Crowd Radio S2:E3 Dr. Paul Cox, PhD, Institute for Ethnomedicine: Environmental Causes of ALS

Dr. Paul Cox, PhD Brain Chemistry Labs – The Institute for Ethnomedicine ethnomedicine.org Interview Date: April 28, 2016 S2:E3 Dr. Paul Alan Cox, Ph.D. speaks about his research approach in studying people to find and fight the environmental causes of ALS.  His research has proven the strong correlation between exposure to an environmental toxin called BMAA and […]

ALS Crowd Radio S2:E1 Dr. Merit Cudkowicz on ALS Research: Progress Since the Ice Bucket Challenge

Dr. Merit E. Cudkowicz, MD, MSc Massachusetts General Hospital Interview Date: April 12, 2016 Dr. Cudkowicz is a leading expert in the field of ALS and is involved in all aspects of research, clinical trials, and patient care. She gives an update of ALS breakthroughs that have occurred over the last two years, since the […]